AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

OrganiGram Inc. (OGI)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.29

-0.03 (-2.27%)

At close: Feb 20, 2025, 3:59 PM

1.30

0.39%

After-hours: Feb 20, 2025, 04:51 PM EST

undefined% (undefined)

Bid	1.29
Market Cap	163.45M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.34
PE Ratio (ttm)	-3.81
Forward PE	n/a
Analyst	Strong Buy

Ask	1.31
Volume	774,175
Avg. Volume (20D)	876,330
Open	1.31
Previous Close	1.32
Day's Range	1.28 - 1.31
52-Week Range	1.27 - 2.91
Beta	undefined

About OGI

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also e...

[Show more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

IPO Date May 21, 2019

Employees 1,093

Stock Exchange NASDAQ

Ticker Symbol OGI

Website https://www.organigram.ca

Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for OGI stock is "Strong Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

OrganiGram Inc. is scheduled to release its earnings on May 13, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-16.76%

Organigram shares are trading lower. The company r... Unlock content with Pro Subscription

2 weeks ago

+7.28%

Cannabis companies are trading higher amid Robert F. Kennedy Jr.'s nomination as HHS secretary and a Senate banking hearing pushing to ease regulations for legal cannabis businesses.

News

1 week ago · benzinga.com

Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years

On Tuesday, Cannabis producer Organigram Holdings Inc OGI reported first-quarter 2025 gross sales of CA$66.8 million, up 19% year-over-year, beating the consensus of CA$65.4 million.

1 week ago · seekingalpha.com

Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript

Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Confere...

1 week ago · zacks.com

OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates

OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.14 per share a year ago.

1 week ago · businesswire.com

Organigram Reports First Quarter Fiscal 2025 Results

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended...

2 weeks ago · businesswire.com

Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, a...

2 months ago · seekingalpha.com

Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade)

Organigram reported Q4-2024 financial results earlier this week and show improved revenues, profit margins, net loss, and increased cash. The company announced the acquisition of Canadian private cann...

2 months ago · seekingalpha.com

Organigram Holdings Inc. (OGI) Q4 2024 Earnings Call Transcript

Organigram Holdings Inc. (NASDAQ:OGI ) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Tim Emberg - CCO Greg Guy...

2 months ago · marketwatch.com

Canada's Organigram shops for U.S. pot businesses with backing from British American Tobacco

Legal cannabis company grows revenue and narrows its loss as it continues its acquisition push.

2 months ago · businesswire.com

Organigram Reports Fourth Quarter and Fiscal 2024 Results

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer (“LP”) of cannabis, announced its results for the fourth quart...

2 months ago · businesswire.com

Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024

Load More News